|
|
| | pepticinnamin E Basic information |
| Product Name: | pepticinnamin E | | Synonyms: | pepticinnamin E;[(2R)-3,6-dioxopiperazin-2-yl]methyl (2S)-2-[[3-(2-chloro-3-hydroxy-4-methoxyphenyl)-2-[[(2R)-3-(4-hydroxyphenyl)-2-[[(E)-3-[2-[(Z)-pent-1-enyl]phenyl]prop-2-enoyl]amino]propanoyl]-methylamino]propanoyl]-methylamino]-3-phenylpropanoate;L-Phenylalanine, N-[(2E)-1-oxo-3-[2-(1Z)-1-penten-1-ylphenyl]-2-propen-1-yl]-D-tyrosyl-2-chloro-3-hydroxy-N,O-dimethyl-L-tyrosyl-N-methyl-, [(2R)-3,6-dioxo-2-piperazinyl]methyl ester | | CAS: | 147317-36-0 | | MF: | C49H54ClN5O10 | | MW: | 908.44 | | EINECS: | | | Product Categories: | | | Mol File: | 147317-36-0.mol |  |
| | pepticinnamin E Chemical Properties |
| Boiling point | 1161.924±65.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.290±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 8.405±0.15(predicted) |
| | pepticinnamin E Usage And Synthesis |
| Uses | Pepticinnamin E is a farnesyl‐transferase inhibitor. |
| | pepticinnamin E Preparation Products And Raw materials |
|